United Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises
Source: SeekingAlpha
2026-07-06 08:45:24 ET
Thesis
Regencell Bioscience Holdings Limited ( RGC ) is a Hong Kong bioscience company conducting research and development in TCM ( Traditional Chinese Medicine ) and its applications in neurocognitive degeneration and disorders. Their primary area of research is on ADHD and Autism, where, per the company's mission, they believe that serious treatment gaps exist not only for patients, but also for their families and caregivers....
Read the full article on Seeking Alpha
For further details see:
United Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises
United Therapeutics Corporation
NASDAQ: UTHR
UTHR Trading
-1.17% G/L:
$529.02 Last:
175,975 Volume:
$535.55 Open:
UTHR Latest News
June 29, 2026 06:30:00 am
United Therapeutics Corporation Announces FDA Approval of the LungFX(TM) Device for Centralized Ex Vivo Lung Perfusion
May 27, 2026 07:00:00 am
United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference
$20,237,032,096
38,621,769
0.2%
368
N/A
Biotechnology & Life Sciences
Healthcare
US
Silver Spring
